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al infections 1）. Currently, the prevalence of acute hep-
atitis B through horizontal transmission tends to be 
increasing. Especially, it is necessary to implement the 
prophylaxis against acute hepatitis by genotype A 
which is regarded as causing a high rate of inducing 
chronic hepatitis B 2～4）. In addition, it needs to prevent 
the poor prognosis of severe hepatitis B（so-called de 
novo hepatitis B）by immunosuppression and chemo-
therapy due to the condition that recognized existing 
HBV infection 5,6）. Moreover, it has a possibility to 
????????????
For the significant purpose of vaccination for hepa-
titis B virus（HBV）in adults, it is an importance of 
prophylaxis against hospital infections and occupation-
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??????????????????：The duration of protection afforded by Hepatitis B（HB）vaccination is unknown. 
We aimed to investigate the antibody persistence and protection from hepatitis B virus infection in medical 
university students.
???????：The subjects were the students of both medical and nursing students who had enrolled at 
Dokkyo Medical University in April, 2012. We evaluated the HB vaccination results in 194 students（medi-
cal：100, nursing：94）who allowed us to observe during a 2-year follow-up. We measured antibody to 
HB surface antigen（anti-HBs）after completing one series of HB vaccinations, at 1 year and at 2 years.
???????：The anti-HBs positive（protective level ≥ 10 mIU/mL）rates of the students were shown after 
completing one series of HB vaccinations, at 1 year and at 2 years respectively. As follows：medical stu-
dents；97.9％→ 80.6％→ 63.3％, nursing students；98.0％→ 84.8％→ 76.1％, and total students；97.9％
→ 82.6％→ 69.5％. The titers of the sustained anti-HBs positive students were significantly higher than 
the titers of the changed negative students of both medical and nursing students after completing HB vac-
cinations for 2 years（P＜0.001, respectively）.
???????????：Approximately 30％ of the students became anti-HBs seronegative during 2 years of fol-
low-up. We should consider if it is necessary to administer additional vaccination for them to boost up 
thereafter.
?????????： hepatitis B virus：HBV, hepatitis B vaccine, anti-HBs, anti-HBs seronegative status, 
medical university students
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cause acute hepatitis B due to post-transfusion 7）. 
From these reasons, HB vaccination will be more sig-
nificant and universal vaccination should be undertak-
en by all Japanese people in the future 7,8）.
In this study, we evaluated the results for HB vac-
cination in both the medical students and the nursing 
students at Dokkyo Medical University. Especially, we 
focused on observing the transition of anti-HBs titers 
from completing one series of vaccinations up to 2 
years later in order to assess the usefulness of HB 
vaccination.
????????????????????
The subjects were the students of both medical and 
nursing students who had enrolled at Dokkyo Medical 
University in April, 2012. Before starting one series of 
the vaccinations, the students were the negative sta-
tus of both HB surface antigen（HBsAg）and anti-
HBs. For a series of vaccinations, the students took 3 
times of HB vaccinations that applied an initial vac-
cine shot, the second one a month later, and the third 
one at 5 months. After completing one series of vacci-
nations, the students were observed for 2 years.
We used precipitated recombinant HB vaccine Bim-
mugen®（The Chemo-Sero-Therapeutic Research 
Institute, Kumamoto）that derived from yeast. The 
administration route was a 10 µg/0.5 mL subcutaneous 
injection for 3 times in one series. Then, we evaluated 
that rate of anti-HBs became positive. We confirmed 
the results of anti-HBs at 4 months period, at 1 year 
and at 2 years by applying chemiluminescent immu-
noassay（CLIA）. Anti-HBs was considered positive if 
the titer was ≥ 10 mIU/mL.
Statistical analyses were performed using Microsoft 
Excel® or IBM SPSS® statistical software. The results 
were expressed as mean±standard deviation（SD）or 
mean±standard error of the mean（SEM）. Differences 
between two independent samples were examined by 
calculating Mann-Whitney U test. A P value of ＜0.05 
was considered significant.
???????
??? ???????????????? ????????
The students were observed for 2 years after one 
series of HB vaccinations that consisted of the medical 
students：100（male：59/female：41）and the mean 
age was 19 .4±1.6 , and the nursing students：94
（male：7/female：87）and the mean age was 18.1±
0.2.
??? ???????????????????????????????????? ?????????
The anti-HBs positive students（rate）were shown 
after completing one series of HB vaccinations, at 1 
year and at 2 years respectively. As follows：medical 
students；98/100（98.0％）→ 79/98（80.6％）→ 62/98
（63.3％）, nursing students；92/94（97.9％）→ 78/92
（84.8％）→ 70/92（76.1％）, total students；190/194
（97.9％）→ 157/190（82.6％）→ 132/190（69.5％）. The 
total students whose anti-HBs status turned out anti-
HBs positive after one series of HB vaccinations, then 
changed to negative during a 2-year follow-up were 
30.5％ .
??? ???????????????????????????????????????????????
???????????????????????????????????????????
??????????
The anti-HBs titers were shown in both the medi-
cal and nursing students at Figure 2.
??? ??????????????????????????????????????????
??????????????????????????????????????
???????????????????????????????????????????
??????????
Regarding the students whose anti-HBs turned out 
positive after one series of HB vaccinations, we com-
pared the students into 2 groups that the sustained 
???????　Summary of studied medical university students
Medical students Nursing students Overall
Number of subjects 100 94 194
Male/Female（％ Male） 59/41（59.0） 7/87（7.4） 66/128（34.0）
Mean age 19.4±1.6 18.1±0.2 18.7±1.3
mean±SD
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anti-HBs positive students and the changed negative 
students during a 2-year follow-up. The anti-HBs 
titers of the sustained positive students were signifi-
cantly higher than the changed negative students in 
both medical and nursing students during 2 years of 
follow-up（P＜0.001, respectively）.
??? ????????????????????????????????????????????
?????????????????????????????????????????????
?????????????? ???????????????????????????
??????????????????????????????????????????????
?????? ?????????
As for a case of male medical student, his anti-HBs 
titer showed positive（159.4 mIU/mL）after complet-
97.9
80.6
63.3
0
10
20
30
40
50
60
70
80
90
100
0 1 2
Medical students
(n=100)
(%)
(Year)
(%)
97.9
82.6
69.5
0
10
20
30
40
50
60
70
80
90
100
0 1 2
Overall
(n=194)
(Year)
98.0 
84.8
76.1
0
10
20
30
40
50
60
70
80
90
100
0 1 2
Nursing students
(n=94)
(Year)
(%)
????????　Transition of anti-HBs positive rate
The rate of anti-HBs positive decreased to 69.5％ after 2 years of HB vaccinations in 
both the medical and nursing students.
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The anti-HBs titers were shown in both the medical and nursing students. Cut off 
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ing one series of vaccinations, and it turned out nega-
tive（8.1 mIU/mL）at 1 year. His anti-HBs titer was 
increased to positive again（21.3 mIU/mL）as a natural 
course observation at 2 years.
??????????
HB vaccination is significantly important to prevent 
vertical HBV infections that transmitted from HBV 
carrier mothers to their newborn infants 9～12）. Further, 
it is possible to cause some horizontal transmission in 
daily life such as father-to-child transmission or 
group infections in nursery schools 13）. In a case of 
HBV infection in adulthood, the 30-50％ of patients is 
likely to develop acute hepatitis after 6 weeks to 
6 months incubation period. Among those patients, a 
little less than 1％ of acute hepatitis is likely to devel-
op into fulminant hepatitis and a considerable number 
of patients could be fatal a outcome7,8）. The infection 
risk rates are 30％ in HBV, 1.8％ in hepatitis C virus
（HCV）and 0.3％ in human immunodeficiency virus
（HIV）. The risk of HBV infection rate is significantly 
high 14）.
For the reasons described as follows, the HB vacci-
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????????　 The comparison between the sustained anti-HBs positive students and the 
changed anti-HBs negative students
The titers of the sustained anti-HBs positive students were significantly higher than the 
titers of the changed anti-HBs negative students in both the medical and nursing stu-
dents（P＜0.001, respectively）.
Cut off value of anti-HBs titer：10 mIU/mL. Data expressed as mean±SEM.
Differences at P＜0.05 were considered significant. ※, ※※, ※※※ P＜0.001.
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????????　 A case of male medical student turned out 
positive as 159.4 mIU/mL after one series of 
HB vaccinations. One year later, the anti-
HBs titer changed to negative as 8.1 mIU/
mL. At 2 years, the anti-HBs titer naturally 
turned out positive again as 21.3 mIU/mL. 
Cut off value of anti-HBs titer：10 mIU/mL.
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nation will be more significant in the future and it is 
considered that universal HB vaccination should be 
undertaken by all Japanese people eventually 7,8）.
Firstly, for the purpose of preventing hospital infec-
tions, HB vaccination should be significantly important 
for doctors and nurses who contact with patients 
directly and also for the janitorial workers who deal 
with laundry and cleaning that may directly contact 
with blood and body fluid of patients. HBV infections 
are likely to happen through needle-stick injuries, cut 
wounds with sharp tools used for patients, exposures 
of mucous membrane with blood and body fluid and 
exposures of wounded skin as small wounds or infec-
tions. Fulminant hepatitis can be infected unknowenly 
through small wounds that are not recognized, urine, 
sweat, saliva or tears from other people 7,8）.
Furthermore, it is important to prevent from devel-
oping acute hepatitis B through horizontal transmis-
sion among adults. Currently, it is proved that HBV 
genotype A is increasing that about 10％ of acute 
hepatitis B in Japan would become chronic and/or 
protracted 15,16）. More than 90％ of co-infection of 
HIV/HBV as STD（sexually transmitted disease）is 
caused by genotype A infection 17,18）. In addition, there 
is a report about the reactivated HBV with complica-
tions after cancer chemotherapy and immunosuppres-
sive therapy. By introducing molecular target drugs, 
it was reported that an emergence of new de novo 
hepatitis B due to the reactivation from a case of 
HBsAg negative 19～21）. And the prevention of post-
transfusion hepatitis B is also important 7～8）.
It is addressed how anti-HBs titer changes with 
time after one series of HB vaccinations 22～24）. For the 
minimum amount of anti-HBs titer in order to pre-
vent HBV infection was defined as 10 mIU/mL in 
accordance with the reference preparation criteria by 
World Health Organization（WHO）and this study was 
applied with that criteria 7,8）. Regarding 97.9％ of the 
total students who turned out anti-HBs seropositive 
after one series of vaccinations, we had observed the 
transition of the anti-HBs titers during a 2-year fol-
low-up. Then 30.5％ of the total students turned out 
the anti-HBs seronegative status. As the results of 
the observation, the titers of the sustained anti-HBs 
positive students were significantly higher compared 
with the titers of the changed anti-HBs negative stu-
dents in both medical and nursing students（P＜0.001, 
respectively）. Consequently, it was proved that the 
anti-HBs titers were high after one series of vaccina-
tions among the sustained anti-HBs positive students. 
As for a factor of the difference between the sus-
tained positive students and the changed negative 
students, it could be involved in the variance of 
immune responsiveness 25）. The transition of anti-HBs 
was hypothetically considered that divided into 4 
types：1）sustained high anti-HBs, 2）decreased from 
high anti-HBs, 3）sustained low anti-HBs, and 4）
decreased from low anti-HBs to negative. We continue 
to follow up the transition of anti-HBs titers at an 
annual physical examination once a year carefully.
Exceptionally, a student’s anti-HBs turned out sero-
positive after HB vaccinations, and then his status 
became negative after one year. Finally, it changed to 
re-anti HBs positive after 2 years（Figure4）. In this 
case, there was a possibility that he was newly-infect-
ed. Also, it could be considered that the result was 
changeable at the respective tests if the anti-HBs 
titer was a relatively low concentration near the 
boundary of negative and positive 7,8）.
Regarding the evaluation for HB vaccination 
responses and the gender differences, generally speak-
ing, the response of females is a favorable clinical 
response 7,8）. It was reported that females have better 
antibody productivity than males 26,27）. One of the rea-
sons is that estradiol allows to enhance the immune 
responsiveness. Therefore, it is pointed out the possi-
bility of the better immunological response because 
females have the higher estradiol consent in the 
serum28）. In this study, we could not evaluate the dif-
ferences by gender. The reason was considered that 
the number of subjects was not well-balanced 
between male and female besides the number sub-
jects itself was not large for the study samples.
After one series of HB vaccinations, the result of 
non-responsive students who had not turned out sero-
positive was 2.1％（4/194）. For the additional counter-
measures against non-responsive students, we have 
tried to repeat 3 injections with regular amount of 
administration 1 year later, to apply the muscle injec-
tion or to change the kind of vaccines 29）. However, it 
is not clarified which countermeasure brings the most 
effective result to gain anti-HBs and this issue will be 
Yayoi Ishikawa6 DJMS
a future study aim7,8）.
In conclusion, approximately 30％ of the students 
turned out anti-HBs seronegative after HB vaccina-
tions during a 2-year follow-up. If cases of the anti-
HBs become positive and then change to negative 
during the process, booster doses are not recommend-
ed for persons with normal immune status who have 
been fully vaccinated in accordance with the guide-
lines by Centers for Disease Control and Prevention
（CDC）in the United States 30）. However, the students 
are placed in the environment with high risk of HBV 
infection. Therefore, it should require considering to 
determine if and when the booster immunization will 
be necessary.
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